
0:00
22:06
When baby KJ was diagnosed with a rare metabolic disorder, the team at Children’s Hospital of Philadelphia (CHOP) had a unique treatment option for him: a personalized gene editing therapy developed in collaboration with Penn Medicine. On this episode, Madeline speaks to CHOP geneticist Dr. Rebecca Ahrens-Nicklas, who describes how KJ’s first-of-its-kind treatment was developed – and what this amazing breakthrough means for other patients.
More episodes from "BREAKING THROUGH with Madeline Bell"



Don't miss an episode of “BREAKING THROUGH with Madeline Bell” and subscribe to it in the GetPodcast app.








